Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Orchestra BioMed Holdings (OBIO) Other Non Operating Income (2022 - 2024)

Orchestra BioMed Holdings (OBIO) has disclosed Other Non Operating Income for 2 consecutive years, with -$11000.0 as the latest value for Q1 2024.

  • Quarterly Other Non Operating Income changed N/A to -$11000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was -$11000.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $254000.0 for FY2025, 2409.09% up from the prior year.
  • Other Non Operating Income for Q1 2024 was -$11000.0 at Orchestra BioMed Holdings, down from $682000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $682000.0 in Q2 2022, with the low at -$11000.0 in Q1 2024.